patiromer

FDA Drug Profile — VELTASSA

Drug Details

Generic Name
patiromer
Brand Names
VELTASSA
Application Number
NDA205739
Sponsor
Vifor Pharma, Inc.
NDC Codes
4
Dosage Forms
POWDER, FOR SUSPENSION
Routes
ORAL
Active Ingredients
PATIROMER

Indications and Usage

1 INDICATIONS AND USAGE Veltassa is indicated for the treatment of hyperkalemia in adults and pediatric patients ages 12 years and older. Limitation of Use: Veltassa should not be used as an emergency treatment for life-threatening hyperkalemia because of its delayed onset of action [see Clinical Pharmacology (12.2) ] . Veltassa is a potassium binder indicated for the treatment of hyperkalemia in adults and pediatric patients ages 12 years and older. ( 1 ) Limitation of Use Veltassa should not be used as an emergency treatment for life-threatening hyperkalemia because of its delayed onset of action. ( 1 )